Black Fungal Injection Price, effects, availability, shortage reason

  • 10.02.2019
  • ITunes

Black Fungal Injection Price, effects, availability, shortage reason

Black Fungus is rare but rising, with India reporting about 140 cases to be the main reason for the current high number of Black Fungus. In some cases, particular fungal and other opportunistic infections have not The effects of etanercept on pregnancy outcomes have been investigated in. Additionally, the growing crisis of “black fungus” infections that each of the 15 authorized COVID-19 vaccines can cause side effects.

Black Fungal Injection Price, effects, availability, shortage reason - think, that

Housing and Health: Time Again for Public Health Action

1. Sharfstein J, Sandel M, eds. Not Safe at Home: How America's Housing Crisis Threatens the Health of Its Children. Boston, Mass: Boston University Medical Center; 1998.

2. Warner M, Barnes PM, Fingerhut LA. Injury and poisoning episodes and conditions. National Health Interview Survey, 1997. Vital Health Stat 10. 2000;No. 202. [PubMed]

3. Karter MJ. Fire Loss in the United States During 1999. Quincy, Mass: National Fire Protection Association; 2000.

4. National Hospital Ambulatory Medical Care Survey: 1998 Emergency Department Summary. Advance Data 313. Hyattsville, Md: National Center for Health Statistics; 2000. Publication PHS 2000-1250. [PubMed]

5. National Center for Environmental Health, Centers for Disease Control and Prevention Web site. Available at: Accessed December 6, 2001.

6. US Census Bureau. American Housing Survey 1999. Available at: Accessed February 19, 2002.

7. Marmot M, Wilkinson R. Social Determinants of Health. New York, NY: Oxford University Press, 1999.

8. Rental Housing Assistance—The Worsening Crisis: A Report to Congress on Worst Case Housing Needs. Washington, DC: US Dept of Housing and Urban Development; 1997.

9. Mood EW. Fundamentals of healthful housing: their application in the 21st century. In: Burridge R, Ormandy D, eds. Unhealthy Housing: Research, Remedies and Reform. New York, NY: Spon Press; 1993:303–337.

10. Marsh BT. Housing and health: the role of the environmental health practitioner. J Environ Health. 1982;45:123–128. [PubMed] [Google Scholar]

11. Howard M. The effects on human health of pest infestations in houses. In: Burridge R, Ormandy D, eds. Unhealthy Housing: Research, Remedies and Reform. New York, NY: Spon Press; 1993:256–282.

12. Stein L. A study of respiratory tuberculosis in relation to housing conditions in Edinburgh; the pre-war period. Br J Soc Med. 1950;4:143–169. [PMC free article] [PubMed] [Google Scholar]

13. Fonseca W, Kirkwood BR, Victora CG, Fuchs SR, Flores JA, Misago C. Risk factors for childhood pneumonia among the urban poor in Fortaleza, Brazil: a case–control study. Bull World Health Organ. 1996;74:199–208. [PMC free article] [PubMed] [Google Scholar]

14. Denny FW Jr. The clinical impact of human respiratory virus infections. Am J Respir Crit Care Med. 1995;152(4 Pt 2):S4–S12. [PubMed] [Google Scholar]

15. Murtagh P, Cerqueiro C, Halac A, Avila M, Salomon H, Weissenbacher M. Acute lower respiratory infection in Argentinian children: a 40 month clinical and epidemiological study. Pediatr Pulmonol. 1993;16:1–8. [PubMed] [Google Scholar]

16. Graham NM. The epidemiology of acute respiratory infections in children and adults: a global perspective. Epidemiol Rev. 1990;12:149–178. [PubMed] [Google Scholar]

17. Wood DL, Valdez RB, Hayashi T, Shen A. Health of homeless children and housed, poor children. Pediatrics. 1990;86:858–866. [PubMed] [Google Scholar]

18. Zolopa AR, Hahn JA, Gorter R, et al. HIV and tuberculosis infection in San Francisco's homeless adults. Prevalence and risk factors in a representative sample. JAMA. 1994;272:455–461. [PubMed] [Google Scholar]

19. Kermode M, Crofts N, Speed B, Miller P, Streeton J. Tuberculosis infection and homelessness in Melbourne, Australia, 1995–1996. Int J Tuberc Lung Dis. 1999;3:901–907. [PubMed] [Google Scholar]

20. Conway J. Ill-health and homelessness: the effects of living in bed-and-breakfast accommodation. In: Burridge R, Ormandy D, eds. Unhealthy Housing: Research, Remedies and Reform. New York, NY: Spon Press; 1993:283–300.

21. Bornehag CG, Blomquist G, Gyntelberg F, et al. Dampness in buildings and health. Nordic interdisciplinary review of the scientific evidence on associations between exposure to “dampness” in buildings and health effects (NORDDAMP). Indoor Air. 2001;11:72–86. [PubMed] [Google Scholar]

22. Peat JK, Dickerson J, Li J. Effects of damp and mould in the home on respiratory health: a review of the literature. Allergy. 1998;53:120–128. [PubMed] [Google Scholar]

23. Hyndman S. Making connections between housing and health. In: Kearns R, Gesler W, eds. Putting Health Into Place: Making Connections in Geographical Research. Syracuse, NY: Syracuse University Press; 1998:191–207.

24. Robinson T, Russell P. Healthy indoor environments for energy efficient housing. In: Health and Ecological Effects: Proceedings of the 9th World Clean Air Congress, August 30–September 4, 1992, Montreal, Quebec, Canada. Pittsburgh, Pa: Air & Waste Management Associates; 1992.

25. Hunt S. Damp and mouldy housing: a holistic approach. In: Burridge R, Ormandy D, eds. Unhealthy Housing: Research, Remedies and Reform. New York, NY: Spon Press; 1993:67–93.

26. Strachan DP. Dampness, mould growth and respiratory disease in children. In: Burridge R, Ormandy D, eds. Unhealthy Housing: Research, Remedies and Reform. New York, NY: Spon Press; 1993:94–116.

27. Marsh A, Gordon D, Pantazis C, Heslop P. Home Sweet Home? The Impact of Poor Housing on Health. Bristol, England: The Policy Press; 1999.

28. Platt SD, Martin CJ, Hunt SM, Lewis CW. Damp housing, mould growth, and symptomatic health state. BMJ. 1989;298:1673–1678. [PMC free article] [PubMed] [Google Scholar]

29. Dales RE, Zwanenburg H, Burnett R, Franklin CA. Respiratory health effects of home dampness and molds among Canadian children. Am J Epidemiol. 1991;134:196–203. [PubMed] [Google Scholar]

30. Brunekreef B, Dockery DW, Speizer FE, Ware JH, Spengler JD, Ferris BG. Home dampness and respiratory morbidity in children. Am Rev Respir Dis. 1989;140:1363–1367. [PubMed] [Google Scholar]

31. Williamson IJ, Martin CJ, McGill G, Monie RD, Fennerty AG. Damp housing and asthma: a case–control study. Thorax. 1997;52:229–234. [PMC free article] [PubMed] [Google Scholar]

32. Markus TA. Cold, condensation and housing poverty. In: Burridge R, Ormandy D, eds. Unhealthy Housing: Research, Remedies and Reform. New York, NY: Spon Press; 1993:141–167.

33. Bierman CW. Environmental control of asthma. Immunol Allergy Clin North Am. 1996;16:753–765. [Google Scholar]

34. Billings CG, Howard P. Damp housing and asthma. Monaldi Arch Chest Dis. 1998;53:43–49. [PubMed] [Google Scholar]

35. Verhoeff AP, van Strien RT, van Wijnen JH, Brunekreef B. Damp housing and childhood respiratory symptoms: the role of sensitization to dust mites and molds. Am J Epidemiol. 1995;141:103–110. [PubMed] [Google Scholar]

36. Karim YG, Ijaz MK, Sattar SA, JohnsonLussenburg CM. Effect of relative humidity on the airborne survival of rhinovirus-14. Can J Microbiol. 1985;31:1058–1061. [PubMed] [Google Scholar]

37. Institute of Medicine. Clearing the Air: Asthma and Indoor Air Exposures. Washington, DC: National Academy Press; 2000.

38. Oie L, Nafstad P, Botten G, Magnus P, Jaakkola JK. Ventilation in homes and bronchial obstruction in young children. Epidemiology. 1999;10:294–299. [PubMed] [Google Scholar]

39. Eggleston PA, Arruda LK. Ecology and elimination of cockroaches and allergens in the home. J Allergy Clin Immunol. 2001;107(suppl 3):S422–S429. [PubMed] [Google Scholar]

40. Platt SD, Martin CJ, Hunt SM, Lewis CW. Damp housing, mould growth, and symptomatic health state. BMJ. 1989;298:1673–1678. [PMC free article] [PubMed] [Google Scholar]

41. Vaughan JW, Platts-Mills TA. New approaches to environmental control. Clin Rev Allergy Immunol. 2000;18:325–339. [PubMed] [Google Scholar]

42. Roberts JW, Dickey P. Exposure of children to pollutants in house dust and indoor air. Rev Environ Contam Toxicol. 1995;143:59–78. [PubMed] [Google Scholar]

43. Rosenstreich DL, Eggleston P, Kattan M, et al. The role of cockroach allergy and exposure to cockroach allergen in causing morbidity among inner-city children with asthma. N Engl J Med. 1997;336:1356–1363. [PubMed] [Google Scholar]

44. Phipatanakul W, Eggleston PA, Wright EC, Wood RA. Mouse allergen, II: the relationship of mouse allergen exposure to mouse sensitization and asthma morbidity in inner-city children with asthma. J Allergy Clin Immunol. 2000;106:1075–1080. [PubMed] [Google Scholar]

45. Collins KJ. Low indoor temperatures and morbidity in the elderly. Age Ageing. 1986;15:212–220. [PubMed] [Google Scholar]

46. Evans J, Hyndman S, Stewart-Brown S, Smith D, Petersen S. An epidemiological study of the relative importance of damp housing in relation to adult health. J Epidemiol Community Health. 2000;54:677–686. [PMC free article] [PubMed] [Google Scholar]

47. Thermal Environmental Conditions for Human Occupancy. Atlanta, Ga: American Society of Heating, Refrigerating, and Air-Conditioning Engineers; 1981. ASHRAE Standard ANSI/ASHRAE 55-1981.

48. Respiratory Health Effects of Passive Smoking. Washington, DC: Environmental Protection Agency; 1992. Publication EPA/600/6-90/006F.

49. Weitzman M, Gortmaker S, Walker DK, Sobol A. Maternal smoking and childhood asthma. Pediatrics. 1990;85:505–511. [PubMed] [Google Scholar]

50. Cook DG, Strachan DP. Health effects of passive smoking, III: parental smoking and prevalence of respiratory symptoms and asthma in school age children. Thorax. 1997;52:1081–1094. [PMC free article] [PubMed] [Google Scholar]

51. Walker E, Hay A. Carbon monoxide poisoning. BMJ. 1999;319:1082–1083. [PMC free article] [PubMed] [Google Scholar]

52. Rosen JF. Adverse health effects of lead at low exposure levels: trends in the management of childhood lead poisoning. Toxicology. 1995;97:11–17. [PubMed] [Google Scholar]

53. Needleman HL, Schell A, Bellinger D, Leviton A, Allred EN. The long-term effects of exposure to low doses of lead in childhood: an 11-year follow-up report. N Engl J Med. 1990;322:83–88. [PubMed] [Google Scholar]

54. Schwartz J. The relationship between blood lead and blood pressure in the NHANES II survey. Environ Health Perspect. 1988;78:15–22. [PMC free article] [PubMed] [Google Scholar]

55. Landrigan PJ. Asbestos—still a carcinogen. N Engl J Med. 1998;338:1618–1619. [PubMed] [Google Scholar]

56. Jaakkola JJ, Oie L, Nafstad P, Botten G, Samuelsen SO, Magnus P. Interior surface materials in the home and the development of bronchial obstruction in young children in Oslo, Norway. Am J Public Health. 1999;89:188–192. [PMC free article] [PubMed] [Google Scholar]

57. Lubin JH, Boice JD Jr. Lung cancer risk from residential radon: meta-analysis of eight epidemiological studies. J Natl Cancer Inst. 1997;89:49–57. [PubMed] [Google Scholar]

58. Lewis RG, Fortmann RC, Camann DE. Evaluation of methods for monitoring the potential exposure of small children to pesticides in the residential environment. Arch Environ Contam Toxicol. 1994;26:37–46. [PubMed] [Google Scholar]

59. Lewis RG, Fortune CR, Willis RD, Camann DE, Antley JT. Distribution of pesticides and polycyclic aromatic hydrocarbons in house dust as a function of particle size. Environ Health Perspect. 1999;107:721–726. [PMC free article] [PubMed] [Google Scholar]

60. Ranson R. Healthy Housing: A Practical Guide. London, England: Spon Press and the World Health Organization Regional Office for Europe; 1991.

61. Home radiator burns among inner-city children: Chicago. MMWR Morb Mortal Wkly Rep. 1996;45:814–815. [PubMed] [Google Scholar]

62. American Academy of Pediatrics. Falls from heights: windows, roofs, and balconies. Pediatrics. 2001;107:1188–1191. [PubMed] [Google Scholar]

63. Nuffield Institute for Health and NHS Centre for Reviews and Dissemination. Preventing falls and subsequent injury in older people. Eff Health Care. 1996;2:1–16. [Google Scholar]

64. Tinetti ME, Speechley M, Ginter SF. Risk factors for falls among elderly persons living in the community. N Engl J Med. 1988;319:1701–1707. [PubMed] [Google Scholar]

65. Dedman DJ, Gunnell D, Davey Smith G, Frankel S. Childhood housing conditions and later mortality in the Boyd Orr cohort. J Epidemiol Community Health. 2001;55:10–15. [PMC free article] [PubMed] [Google Scholar]

66. Ellaway A, Macintyre S, Fairley A. Mums on Prozac, kids on inhalers: the need for research on the potential for improving health through housing interventions. Health Bull. 2000;54:336–339. [PubMed] [Google Scholar]

67. Meyers A, Frank DA, Roos N, et al. Housing subsidies and pediatric undernutrition. Arch Pediatr Adolesc Med. 1995;149:1079–1084. [PubMed] [Google Scholar]

68. Collins KJ. Cold and heat-related illnesses in the indoor environment. In: Burridge R, Ormandy D, eds. Unhealthy Housing: Research, Remedies and Reform. New York, NY: Spon Press; 1993:117–140.

69. Heat-related deaths—Los Angeles County, California, 1999–2000, and United States, 1979–1998. MMWR Morb Mortal Wkly Rep. 2001;50:623–625. [PubMed] [Google Scholar]

70. Hyndman SJ. Housing dampness and health amongst British Bengalis in east London. Soc Sci Med. 1990;30:131–141. [PubMed] [Google Scholar]

71. Hopton JL, Hunt SM. Housing conditions and mental health in a disadvantaged area in Scotland. J Epidemiol Community Health. 1996;50:56–61. [PMC free article] [PubMed] [Google Scholar]

72. Gabe J, Williams P. Women, crowding and mental health. In: Burridge R, Ormandy D, eds. Unhealthy Housing: Research, Remedies and Reform. New York, NY: Spon Press; 1993:191–208.

73. Zima BT, Wells KB, Freeman, HE. Emotional and behavioral problems and severe academic delays among sheltered homeless children in Los Angeles County. Am J Public Health. 1994;84:260–264. [PMC free article] [PubMed] [Google Scholar]

74. Gilloran JL. Social problems associated with “high living.” Med Officer. 1968;120:117–118. [Google Scholar]

75. Dunn JR, Hayes MV. Social inequality, population health, and housing: a study of two Vancouver neighborhoods. Soc Sci Med. 2000;51:563–587. [PubMed] [Google Scholar]

76. McEwen BS, Seeman T. Protective and damaging effects of mediators of stress: elaborating and testing the concepts of allostasis and allostatic load [review]. Ann N Y Acad Sci. 1999;896:30–47. [PubMed] [Google Scholar]

77. Henkin RI, Knigge KM. Effects of sound on hypothalamic-pituitary-adrenal axis. Am J Physiol. 1963;204:701–704. [PubMed] [Google Scholar]

78. Van Cauter E, Spiegel K. Sleep as a mediator of the relationship between socioeconomic status and health: a hypothesis. Ann N Y Acad Sci. 1999;896:254–261. [PubMed] [Google Scholar]

79. Sampson RJ, Raudenbush SW, Earls F. Neighborhoods and violent crime: a multilevel study of collective efficacy. Science. 1997;277:918–924. [PubMed] [Google Scholar]

80. Cubbin C, LeClere FB, Smith GS. Socioeconomic status and injury mortality: individual and neighbourhood determinants. J Epidemiol Community Health. 2000;54:517–524. [PMC free article] [PubMed] [Google Scholar]

81. Pearl M, Braveman P, Abrams B. The relationship of neighborhood socioeconomic characteristics to birthweight among 5 ethnic groups in California. Am J Public Health. 2001;91:1808–1814. [PMC free article] [PubMed] [Google Scholar]

82. Diez Roux AV, Merkin SS, Arnett D, et al. Neighborhood of residence and incidence of coronary heart disease. N Engl J Med. 2001;345:99–106. [PubMed] [Google Scholar]

83. Wallace R. Synergism of plagues: “planned shrinkage,” contagious housing destruction, and AIDS in the Bronx. Environ Res. 1988;47:1–33. [PubMed] [Google Scholar]

84. Cohen D, Spear S, Scribner R, Kissinger P, Mason K, Wildgen J. “Broken windows” and the risk of gonorrhea. Am J Public Health. 2000;90:230–236. [PMC free article] [PubMed] [Google Scholar]

85. Barr RG, Riez-Roux AV, Knirsch CA, Pablos-Mendez A. Neighborhood poverty and the resurgence of tuberculosis in New York City, 1984–1992. Am J Public Health. 2001;91:1487–1493. [PMC free article] [PubMed] [Google Scholar]

86. Schulz A, William D, Israel B, et al. Unfair treatment, neighborhood effects, and mental health in the Detroit metropolitan area. J Health Soc Behav. 2000;41:314–332. [PubMed] [Google Scholar]

87. Centers for Disease Control and Prevention. Neighborhood safety and the prevalence of physical inactivity—selected states, 1996. MMWR Morb Mortal Wkly Rep.M 1999;48;143–146. [PubMed] [Google Scholar]

88. Brownson RC, Baker EA, Housemann RA, Brennan LK, Bacak SJ. Environmental and policy determinants of physical activity in the United States. Am J Public Health. 2001;91:1995–2003. [PMC free article] [PubMed] [Google Scholar]

89. Yen IH, Kaplan GA. Neighborhood social environment and risk of death: multilevel evidence from the Alameda County Study. Am J Epidemiol. 1999;149:898–907. [PubMed] [Google Scholar]

90. Bosma H, van de Mheen D, Borsboom GJJM, Mackenbach JP. Neighborhood socioeconomic status and all-cause mortality. Am J Epidemiol. 2001;153:363–371. [PubMed] [Google Scholar]

91. Haan M, Kaplan GA, Camacho T. Poverty and health: prospective evidence from the Alameda County Study. Am J Epidemiol. 1987;125:989–998. [PubMed] [Google Scholar]

92. Perlin SA, Wong D, Sexton K. Residential proximity to industrial sources of air pollution: interrelationships among race, poverty, and age. J Air Waste Manage Assoc. 2001;51:406–421. [PubMed] [Google Scholar]

93. Stansfeld S, Haines M, Brown B. Noise and health in the urban environment. Rev Environ Health. 2000;15:43–82. [PubMed] [Google Scholar]

94. Jackson RJ, Kochtitsky C. Creating a Healthy Environment: The Impact of the Built Environment on Public Health. Washington, DC: Sprawl Watch Clearinghouse Mongraph Series; 2001.

95. Frumkin H. Beyond toxicity, I: human health and the natural environment. Am J Prev Med. 2001;20:234–240. [PubMed] [Google Scholar]

96. Fullilove MT, Heon V, Jimenez W, Parsons C, Green LL, Fullilove RE. Injury and anomie: effects of violence on an inner-city community. Am J Public Health. 1998;88:924–927. [PMC free article] [PubMed] [Google Scholar]

97. Huss K, Rand CS, Butz AM, et al. Home environmental risk factors in urban minority asthmatic children. Ann Allergy. 1994;72:173–177. [PubMed] [Google Scholar]

98. Kane MP, Jaen CR, Tumiel LM, Bearman GM, O'Shea RM. Unlimited opportunities for environmental interventions with inner-city asthmatics. J Asthma. 1999;36:371–379. [PubMed] [Google Scholar]

99. Ranson R. Accidents at home: the modern epidemic. In: Burridge R, Ormandy D, eds. Unhealthy Housing: Research, Remedies and Reform. New York, NY: Spon Press; 1993:223–255.

100. The Glasgow House Condition Survey. Glasgow, Scotland: City of Glasgow; 1985.

101. Boardman B. Prospects for affordable warmth. In: Burridge R, Ormandy D, eds. Unhealthy Housing: Research, Remedies and Reform. New York, NY: Spon Press; 1993:282–400.

102. Rosen G. A History of Public Health. New York, NY: MD Publications; 1958.

103. Engels F. The Condition of the Working Class in England. New York, NY: Panther Books; 1969.

104. Byrne D, Keithley J. Housing and the health of the community. In: Burridge R, Ormandy D, eds. Unhealthy Housing: Research, Remedies and Reform. New York, NY: Spon Press; 1993:41–66.

105. Walker WF. Some relation between our health and our environment. Am J Public Health. 1923;13:897–914. [PMC free article] [PubMed] [Google Scholar]

106. McKeown T. The Role Of Medicine—Dream, Mirage or Nemesis. London, England: Nuffield Provincial Hospitals Trust; 1976.

107. Jacobs M, Stevenson G. Health and housing: a historical examination of alternative perspectives. Int J Health Serv. 1981;1:105–122. [PubMed] [Google Scholar]

108. Rosner D, ed. Hives of Sickness: Public Health and Epidemics in New York City. New Brunswick, NJ: Rutgers University Press; 1995.

109. Veiller L. Housing as a factor in health progress in the past fifty years. In: Ravenel MP, ed. A Half Century of Public Health. New York, NY: American Public Health Association; 1921:323–334.

110. Duffy J. A History of Public Health in New York City 1866–1966. New York, NY: Russell Sage Foundation; 1974.

111. Galishoff S. Newark: The Nation's Unhealthiest City 1832–1895. New Brunswick, NJ: Rutgers University Press; 1988.

112. Melosi MV. The Sanitary City: Urban Infrastructure in America From Colonial Times to the Present. Baltimore, Md: Johns Hopkins University Press; 2000. [PubMed]

113. Wohl AS. Endangered Lives: Public Health in Victorian Britain. Cambridge, Mass: Harvard University Press; 1983.

114. Coleman W. Death Is a Social Disease: Public Health and Political Economy in Early Industrial France. Madison: University of Wisconsin Press; 1982.

115. Evans RJ. Death in Hamburg: Society and Politics in the Cholera Years 1830–1910. Oxford, England: Clarendon Press; 1987.

116. DeForest RW, Veiller L. The tenement house problem. In: DeForest RW, Veiller L. The Tenement House Problem. Vol 1. New York, NY: MacMillan Co; 1903:18.

117. Sanitary Conditions of the City, Report of the Council of Hygiene and Public Health of the Citizens' Association of New York. New York, NY: Council of Hygiene and Public Health of the Citizens' Association of New York; 1865. [PMC free article] [PubMed]

118. Chadwick E. Report on the Sanitary Condition of the Labouring Population of Gt. Britain, by Edwin Chadwick. 1842. Flinn MW, ed. Edinburgh, Scotland: University Press. 1965.

119. Griscom JC. The Sanitary Condition of the Laboring Population of New York With Suggestions for Its Improvement. New York, NY: Harper and Bros; 1845.

120. Riis JA. How the Other Half Lives: Studies Among the Tenements of New York. New York, NY: Charles Schribner's Sons; 1890.

121. Markowitz G, Rosner D. “Cater to the children”: the role of the lead industry in a public health tragedy, 1900–1955. Am J Public Health. 2000;90:36–46. [PMC free article] [PubMed] [Google Scholar]

122. Fee E. Public health in practice: an early confrontation with the “silent epidemic” of childhood lead paint poisoning. J Hist Med Allied Sci. 1990;45:570–606. [PubMed] [Google Scholar]

123. Winslow CEA. Health and housing. In: Housing for Health. Lancaster, Pa: Science Press Printing Company; 1941.

124. Housing and Health: The Proceedings of a Round Table at the 27th Annual Conference of the Milbank Memorial Fund. New York, NY: Milbank Memorial Fund; 1951:5.

125. Basic Principles of Healthful Housing. New York, NY: American Public Health Association; 1938. [PMC free article] [PubMed]

126. Basic Health Principles of Housing and Its Environment; APHA-PHS Recommended Housing Maintenance and Occupancy Ordinance. Washington, DC: American Public Health Association; 1971. [PMC free article] [PubMed]

127. APHA Program Area Committee on Housing and Health, 1968. Basic health principles of housing and its environment. Am J Public Health. 1969;59:841–851. [PMC free article] [PubMed] [Google Scholar]

128. Mood EW. APHA-CDC Recommended Minimum Housing Standards. Washington, DC: American Public Health Association; 1986.

129. APHA policy statements. 9916: public health role of codes regulating design, construction and use of buildings. Available at: Accessed February 19, 2002.

130. APHA policy statements. 200019: public health role of the National Fire Protection Association on setting codes and standards for the built environment. Am J Public Health. 2001;91:503–504. [PMC free article] [PubMed] [Google Scholar]

131. Pauls J. APHA's growing involvement with international standards and codes development activity affecting the built environment. Injury Control and Emergency Health Services Section Newsletter, Fall 2000. Available at: Accessed February 19, 2002.

132. Guidelines on assessment and remediation of fungi in indoor environments. Available at: Accessed March 1, 2002.

133. Krieger JW, Song L, Takaro TK, Stout J. Asthma and the home environment of low-income urban children: preliminary findings from the Seattle-King County healthy homes project. J Urban Health. 2000;77:50–67. [PMC free article] [PubMed] [Google Scholar]

134. Krieger J, Takaro T, Allen C, et al. The Seattle-King County Healthy Homes Project: implementation of a comprehensive approach to improving indoor environmental quality for low-income children with asthma. Environ Health Perspect. 2002;110(suppl 2):311–322. [PMC free article] [PubMed] [Google Scholar]

135. Centers for Disease Control and Prevention. About lead. Available at: Accessed February 19, 2002.

136. Dept of Housing and Urban Development. HUD awards over $67 million to protect children from dangerous lead and other environmental hazards. Available at: Accessed February 19, 2002.

137. Roderick P, Victor C, Connelly J. Is housing a public health issue? A survey of directors of public health. BMJ. 1991;302:157–160. [PMC free article] [PubMed] [Google Scholar]

138. Somerville M, Mackenzie I, Owen P, Miles D. Housing and health: does installing heating in their homes improve the health of children with asthma? Public Health. 2000;114:434–439. [PubMed] [Google Scholar]

139. Freudenberg N. Community organization, housing, and health: a perspective for public health workers. Bull N Y Acad Med. 1990;66:451–462. [PMC free article] [PubMed] [Google Scholar]

140. Carp FM. Impact of improved living environment on health and life expectancy. Gerontologist. 1977;17:242–249. [PubMed] [Google Scholar]

141. Wambem DB, Piland NF. Effects of improved housing on health in South Dos Palos, Calif. Health Serv Rep. 1973;88:47–58. [PMC free article] [PubMed] [Google Scholar]

142. Harving H, Korsgaard J, Dahl R. Clinical efficacy of reduction in house-dust mite exposure in specially designed, mechanically ventilated “healthy” homes. Allergy. 1994;49:866–870. [PubMed] [Google Scholar]

143. Thomson H, Petticrew M, Morrison D. Health effects of housing improvement: systematic review of intervention studies. BMJ. 2001;323:187–190. [PMC free article] [PubMed] [Google Scholar]

144. Katz LF, King JR, Liebman JB. The early impact of moving to opportunity in Boston. October 2000. Available at: Accessed November 10, 2001.

145. Douglas MR, Mallonee S, Istre GR. Comparison of community based smoke detector distribution methods in an urban community. Inj Prev. 1998;4:28–32. [PMC free article] [PubMed] [Google Scholar]

146. Raw GJ, Prior J. The environmental assessment of new houses. In: Burridge R, Ormandy D, eds. Unhealthy Housing: Research, Remedies and Reform. New York, NY: Spon Press; 1993:361–381.

147. Wargocki P, Sundell J, Bischoff W, et al. Ventilation and health in nonindustrial environments. Report from a European Multidisciplinary Scientific Consensus Meeting. Clima 2000/Napoli 2001 World Congress, Napoli (I), 15–18 September 2001. Indoor Air. 2002. In press.

148. Standards for Ventilation Required for Minimum Acceptable Indoor Air Quality. Atlanta, Ga: American Society of Heating, Refrigerating, and Air-Conditioning Engineers; 1981. ASHRAE Standard ANSI/ASHRAE 62-1981.

149. Douglas MJ, Conway L, Gorman D, Gavin S, Hanlon P. Developing principles for health impact assessment. J Public Health Med. 2001;23:148–154. [PubMed] [Google Scholar]

150. Lock K. Health impact assessment. BMJ. 2000;320:1395–1398. [PMC free article] [PubMed] [Google Scholar]

151. Burridge R, Ormandy D. The legal environment of housing conditions. In: Burridge R, Ormandy D, eds. Unhealthy Housing: Research, Remedies and Reform. New York, NY: Spon Press; 1993:420–423.

152. Mannino DM, Homa DM, Pertowski CA, et al. Surveillance for asthma—United States, 1960–1995. Mor Mortal Wkly Rep CDC Surveill Summ. 1998;47:1–27. [PubMed] [Google Scholar]

153. Gergen PJ. The increasing problem of asthma in the United States. Am Rev Respir Dis. 1992;146:823–824. [PubMed] [Google Scholar]

154. Pierce J, Orlando D, Hortman P, Risco, Powell KE, Division of Environmental Hazards and Health Effects, CDC. Corporate action to reduce air pollution—Atlanta, Georgia, 1998–1999. MMWR Morb Mortal Wkly Rep. 2000;49:153–156. [Google Scholar]

Источник: []

Covid-19 crisis The battle against Black Fungus, White Fungus and Coronavirus" width="715">

The Centre on Thursday directed all state and UT governments to declare Mucormycosis, known as ‘Black Fungus’, a notifiable disease under the Epidemic Diseases Act, after reports came about 126 deaths due to this deadly disease till now across India. Nearly 5,500 cases have been officially reported till now from different states.

The key drug, Liposomal amphotericin B, used for the treatment of Black Fungus, has now become scarce in Delhi and nine other states and the Centre has asked pharma companies to ramp up production on a war scale. In Delhi, there are more than 200 patients suffering from Black Fungus undergoing treatment in different hospitals. Most of them are aged above 50 years. Maharashtra is the worst-hit state with 90 deaths so far, followed by 14 deaths in Haryana. Meanwhile, reports came in of White Fungus surfacing in Patna, the capital of Bihar.

With the AIIMS issuing guidelines about detection and treatment of Black Fungus disease, I spoke to Dr Nikhil Tandon, Head of department of endocrinology, metabolism and diabetes, in my prime time show ‘Aaj Ki Baat’ on Thursday night, about various issues relating to this deadly epidemic. He is considered an expert on fungal infection.

During the interview, Dr Tandon made some points clearly: One, neither black fungus nor white fungus are new diseases, there are fungii in our environment, but earlier there were very, very few such fungus-related  cases, but due to widespread use of strong steroids during Covid-19 treatment, the black fungus surfaced and targeted mostly diabetics, who have lower immunity. This black fungus attacks the small blood vessels and capillaries.

Two, timely detection of the disease can save a patient. Dr Tandon advised people not to self-medicate if they have problems like cough, cold and fever. Secondly, he asked people to be on the look out for symptoms like red eyes, swollen face, blurred images and spots on face. Do not be scared, go to a specialist and get yourself checked through different tests. This disease cannot be treated at home. It can be treated only in hospitals. Dr Tandon also explained what precautions people should take after recovering from Covid-19. Both the Centre and state governments are now alert about Black Fungus disease, and efforts are being made to provide adequate stocks of the key drug to all states.

White Fungus disease has been detected in Patna Medical College hospital, where nearly 50 Black Fungus patients are undergoing treatment. On Thursday, four new cases of White Fungus were detected. Doctors in the Patna hospital became worried when they noticed this deadly white fungus disease, which attacks the lungs and the chest cavity first, and then spreads to other organs in the body.

Our Patna reporter Nitish Chandra reported that in all the white fungus patients, the initial symptoms were cough followed by fever. When the oxygen saturation level started dipping, HRCT scan was carried out, which showed patches on lungs of patients. The symptoms were similar to those of Covid-19 patients. The surprising part was that all Rapid Antigen and RT-PCR tests conducted on these patients showed negative, but the patches on lungs gave vital clues to doctors.

One of the patients was a doctor himself, who insisted on getting his sputum tests done through culture, and the white fungus was detected. He was given anti-fungal drugs, and he recovered within three days. Our reporter spoke to the doctor Dr Basant Kumar, who said, he had a clear inkling that he has caught a fungal infection. When the Covid-19 test showed negative, he insisted on fungal infection test, and the fungus was caught in time.

White fungus is basically one, which is also known as Candidosis, that grows in moist skin parts of a human body. It basically surfaces due to weakened immune system, but can also be a side-effect of chemotherapy or antibiotic treatment. Fungi are generally found in water, air and surface. When kids wear diapers, they get skin rashes, while some people get ulcers inside their mouth. These are due to presence of fungus. Such fungi are treated with normal medicines, but if the fungus reaches the lungs, it becomes deadly. Both black fungus and white fungus attack those who have a weakened immune system, or those who are suffering from diabetes, AIDS or cancer. Doctors say, use of ordinary tap water in place of distilled water by people using oxygen cylinders in home, can also cause fungus infection in the lungs through nose and throat while inhaling oxygen.

The Centre has said that a multi-disciplinary approach is required for treatment of all black fungus and white fungus patients. Eye surgeons, ENT specialists, general surgeon and neuro surgeons should be part of this team. Health Ministry and Indian Council of Medical Research has formulated guidelines to be followed by all government hospitals, medical colleges and private hospitals for screening, diagnosis and management of all black fungus and white fungus cases. New cases are being reported daily from Delhi, Gurugram, Mumbai, Ahmedabad, Lucknow, and other cities of Maharashtra, Haryana and Bihar.

Delhi government has started preparing separate black fungus wards in LNJP hospital, GTB Hospital and Rajiv Gandhi Hospital. More than 400 black fungus patients are presently admitted in Ahmedabad Civil Hospital. Doctors and patients in almost all states are facing problem of availability of Liposomal injections.

With fungal infections spreading in states, the Centre on Thursday issued an alert about Coronavirus transmission. The office of the Principal Scientific Adviser to the Government of India issued an advisory titled “Stop the Transmission, Crush the Pandemic”. It cautioned people about aerosols carrying the deadly virus can travel in air up to a distance of 10 metres.

The advisory said: “Always Remember: People who show no symptoms can also spread the virus”. Proper ventilation can prevent the spread of the virus. Running air conditioners while keeping windows and doors shut, traps infected air inside the room, and increases risk of transmission from an infected carrier to others.” The advisory also recommended use of gable fan systems and roof ventilators in offices, auditoriums, shopping malls and other closed public spaces. “Frequent cleaning and replacement of filters is highly recommended.”

On aerosol and droplet transmission, the advisory said, saliva and nasal discharges in the form of droplets and aerosols by an infected person in the primary mode of virus transmissions. “Droplets emitted by an infected person land on various surfaces (where they can survive for a long time). As such, frequent cleaning of high contact points such as door handles, light switches, tablets, chairs and the floor with disinfectants like bleach and phenyl is recommended.”

The advisory said, community level testing and isolation will have to be ramped up in semi-urban and rural areas. Rapid antigen tests are a must for outsiders entering a locality, and wearing of N95 mask by health workers is essential. The Centre has a target of achieving 45 lakh Covid tests daily. Orders have been issued to procure  rapid antigen kits. This will help in early detection and treatment of people infected with Covid-19.

It is a fact that thousands of people faced hardships and ordeals till last week due to the deadly second wave of the pandemic. There were severe shortages of oxygen supply and oxygen cylinders during those one and half months. They had to run from pillar to post in search of hospital beds and ICU ventilators. They had to wait in long queues with the bodies of their dear ones for cremation outside crematoriums. The situation has now turned for the better. There is no shortage of hospital beds. In most of the hospitals, beds are now available. Oxygen is now available in plenty, thanks to the wartime-like efforts made by Indian Railways, Indian Air Force and Navy. Army and paramilitary forces set up Covid hospitals to treat the needy.

Now that the situation has somewhat eased, let us vow never to drop our guard and be eternally vigilant against this deadly virus. Get yourself tested at the first hint of any Covid symptom, and isolate yourself immediately. Please do not self-medicate. It enhances the risks by several times. Consult a doctor. Do not take your mask lightly. Better wear a double mask which should fully cover your nose and mouth. The nation can survive only if all of us survive. The next important part is: vaccination. Every Indian needs to be vaccinated. The stocks of vaccines may be low presently, but the Centre has promised to bring in more stocks by next month. The next three months will witness a flurry of vaccination doses. Our war against Corona shall continue till the time 70 percent of Indians are not vaccinated.

Aaj Ki Baat: Monday to Friday, 9 PM

India's Number One and the most followed Super Prime Time News Show 'Aaj Ki Baat – Rajat Sharma Ke Saath' was launched just before the 2014 General Elections. Since its inception, the show is redefining India's super-prime time and is numerically far ahead of its contemporaries.

Latest India News

Источник: []

Kin of patients affected by Mucormycosis shelling out lakhs for treatment

Even after winning the battle against Covid-19, there is no respite for many patients who are falling prey to a black fungus infection — mucormycosis. A serious but rare fungal infection, mucormycosis is caused by a group of molds called mucormycetes. It causes blindness, organ dysfunction, loss of body tissue and even death if not treated on time, said doctors.

Due to the sudden surge in the price of life-saving antifungal medicines, patients at private hospitals have to shell out lakhs during their treatment that stretches between four-six weeks.

Siddhesh Parulekar, 71, who recovered from Covid-19, lost his left eye to mucormycosis. The Girgaum resident was detected with Covid-19 in April. With moderate infection - his oxygen saturation levels were around 92 -he underwent treatment at the Worli Covid care centre for almost two weeks and returned home. But within a month, his left eye started drooping and he started squinting. When he was rushed to an ophthalmologist, his MRI report revealed that he had been infected with mucormycosis. On May 9, he was admitted to Saifee Hospital. Struggling to arrange ₹10 lakh for the treatment, the family has started a campaign on the crowdfunding portal—

“Last week, he underwent surgery where his left eye was removed. His condition is quite critical as the fungus has reached his brain. Currently, he is in the intensive care unit (ICU),” said his son Sunil Parulekar.

In another case, Sudhir Mishra, 56, is raising funds for his father’s treatment who has been diagnosed with mucormycosis. Only last month, Mishra spent ₹4 lakhs on his father Anand who was tested positive for Covid-19. Currently, Anand is at Lotus hospital, Borivali that has given the family an estimate of ₹12lakhs towards the treatment of mucormycosis.

Pre-Covid-19, patients with mucormycosis were treated at half the current expense. With the sudden surge in mucormycosis cases, however, there has been a severe shortage of life-saving drug — Liposomal Amphotericin B in the market. Taking advantage of the increasing demand, drug suppliers have increased the price of one injection from ₹8,000 to over ₹10,000, said doctors.

“There are two types of drugs—Liposomal Amphotericin B and plain Amphotericin B.

During pre-Covid days, the first one used to cost ₹3000-5,000. The latter one was ₹150. However, we preferred giving Liposomal Amphotericin B as it is more effective even for Rhino mucormycosis when the infection reaches the brain. So, during the second wave, when cases increased, suppliers surged their price to over ₹10,000. While the price of Amphotericin B has been raised to ₹500,” said Dr ChandraVeer Singh, consultant otorhinolaryngologist, head and neck onco-surgeon, Wockhardt Hospital, Mira Road.

As per treatment protocol, when the black fungus infects the nose, sinus or palate, doctors give 5mg dose per kilogram (kg) of body weight. For instance, if a person is 60kgs, he would require 300mg of the dose. Each vial consists of 50mg of the drugs. So, a patient needs six vials which costs ₹60,000 daily. But when the infection reaches the brain, doctors have to give 8-10mg per kg of the body weight. This doubles the daily medical expenditures.

Dr Milind Navalakhe, consultant ENT, Global Hospital, Parel said that plain Amphotericin B often affects the kidneys so patients who can afford the medical expenditure opt for Liposomal Amphotericin B. “Patients have to spend a minimum of ₹60,000 daily on the medicines for four-six weeks,” he said.

After receiving several complaints of overcharging and channelise the supply of these drugs, hospitals have been instructed to procure the injections directly through the collector’s office.

“For the last two-three days, case wise, we send the details to the collector’s office who then supply us the injections. This has helped break the chain of middlemen and over-pricing of doses,” said Dr Singh.

Abhay Pandey, national president of All Food and Drug Licence Holder Foundation (AFDLHF) said mucormycosis before Covid-19 was considered an extremely rare fungal infection. A handful of pharmaceutical companies produce the Liposomal Amphotericin B. Now, with the surge in cases, companies are struggling to meet the demand and arrange for raw materials. “When the pandemic started in March last year, the suppliers increased the price of masks and sanitisers for their profit. So now, as cases of mucormycosis have increased, they are using the opportunity by surging prices of the injections,” he said.

A spokesperson from Cipla which is one of the manufacturers of the injection said, “The demand for the antifungal medicines has increased by 3-4 times. We are getting orders from all across the country. We have escalated the production and we believe the demand will soon be met.”

Meanwhile, doctors said unlike last year the black fungal infection during the second wave is more aggressive which deteriorates the condition of the patients faster.

“In the second wave, the infection rate is not only more but it is also affecting younger patients. I have a patient who is just 25-year-old. Also, the infection is so aggressive that it is quickly spreading to eyes, palate and even brain,” said Navalakhe.

Doctors said incidences of mucormycosis can be controlled by stopping the unregulated usage of insulin. “This black fungus was earlier visible among patients with immunosuppressants like diabetes and cancer. Patients with Covid-19 are unnecessarily given a large number of steroids which compromises their immunity. So, it (dispensing steriods) needs to be controlled,” said Dr Shashank Joshi, part of the state’s Covid-19 task force.

Get our Daily News Capsule

Thank you for subscribing to our Daily News Capsule newsletter.

Close StoryИсточник: []
Herd immunity for Covid only after October but vaccination needs to be scaled up: SBI report

Treatment and Shortage of Drugs

On the treatment front, doctors use an anti-fungal injection known as Amphotericin B to treat life-threatening cases. However, with growing demand, hospitals in Pune are facing severe shortages of the drug that could lead to patients racking up hefty bills for treatment.

Daily demand for the drug in the city has reached 1,000 vials, even though supply is limited to 200 to 500 vials a day, according to a report by The Times of India. Fearing a blow up in prices, doctors have urged the Centre to cap the retail price as it did with Remdesvir.

While the resurfacing of the fungal disease is concerning, cases of Mucormycosis had been seen in patients last year as well. Hospitals in Ahmedabad, Delhi and Bengaluru had flagged cases in November-December last year.

Источник: []